Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01589809Phase 2Unknown
A Phase 2 trial of nicotinamide in Friedreich's ataxia (FA), sponsored by Imperial College London. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01589809.